Changes in platelet aggregation after suspension of aspirin therapy.
Furukawa
Kojiro
K
Department of Cardiovascular Surgery, Saga Prefectural Hospital, Koseikan, Saga, Japan. furukawa@bcm.tmc.edu
Ohteki
Hitoshi
H
D000368:Aged; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000379:methods; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000379:methods; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects* / Q000502:physiology; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D011237:Predictive Value of Tests; D011300:Preoperative Care; D011379:Prognosis; D011446:Prospective Studies; D018570:Risk Assessment; D012494:Sampling Studies; D013997:Time Factors
D001241:Aspirin